The Efficacy and Hemorheological Indexes of Ginseng and Its Active Components for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Yawen XiaHongkuan HanRenjun GuRuizhi TaoKeqin LuZhiguang SunSanbing ShenAiyun Wang Yin Lu

Published in: Journal of oncology (2023)

It is a reasonable choice to use ginseng and its active components as adjuvant therapy for NSCLC. Ginseng is helpful for NSCLC patients' conditions, immune cells, cytokines, and secretions in the serum.

Keyphrases

small cell lung cancer
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
advanced non small cell lung cancer
early stage
prognostic factors
patient reported outcomes